微泡源性EGFRvIII对多形性胶质母细胞瘤电离辐射效应的影响及机制研究

批准号:
81372712
项目类别:
面上项目
资助金额:
70.0 万元
负责人:
任精华
依托单位:
学科分类:
H1816.肿瘤放射治疗
结题年份:
2017
批准年份:
2013
项目状态:
已结题
项目参与者:
梁慧芳、何文山、彭纲、刘俊丽、李勤、李大鹏、刘翠微、蔡茜
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
微泡(MV)是新近发现的细胞间通讯的重要介质,是不同表型细胞间互通有无的关键途径。基于近期胶质母细胞瘤(GBM)来源微泡横向传递EGFRvIII的重大发现,本课题组围绕EGFRvIII-MV对受体细胞放射敏感性的影响展开了研究。我们前期研究发现,电离辐射诱导MV的分泌、释放;外源性EGFRvIII-MV通过膜融合途径使GBM受体细胞获得性表达EGFRvIII,促进电离辐射后DNA双链断裂(DSB)修复,下调其放射敏感性,是异质性细胞间协同抵抗电离辐射的潜在机制。本项目拟在上述基础上,从临床角度探明外周血中EGFRvIII-MV浓度与GBM患者放疗疗效和预后之间的联系;深入研究离体和在体条件下微泡源性EGFRvIII对受体细胞PI3K/Akt、DNA-PKcs、DNA DSB修复及放射敏感性的影响。开展本课题有助于进一步认识微泡在GBM放射抵抗中的作用,为肿瘤放射增敏提供新思路。
英文摘要
Microvesicles are plasma-membrane-derived particles that released from cells by the outward budding and fission of the plasma membrane. As a novel mediator of intercellular communication, microvesicle transfer bioactive lipids and proteins, including oncogene products and receptors, from the cell of origin to recipient cells. Recently, microvesicle derived from tumor cells transfer the oncogenic receptor EGFRvIII from more aggressive to indolent glioma cells, which shed light on a flexible interoperability mechanism among different tumor-cell subsets. EGFRvIII, a truncated and oncogenic form of the epidermal growth factor receptor variant, has been implicated to confer radiation resistance of glioblastoma multiforme (GBM). However, the effect of EGFRvIII-MV on radiosensitivity of GBM remains to be elucidated. Using scanning electron microscopy, we have discovered that IR triggers the generation and secretion of microvesicles. Interestingly, we demonstrated that incubation for 24 hours prior to irradiation with microvesicles resulted in a significant decrease of radiosensitivity in U87 human glioblastoma cell. Based on these discoveries, we hypothesize that membrance microvesicles containing EGFRvIII may represent a critical survival mechanism for glioblastoma cells against IR by horizontal propagation of oncogenes and phenotype transformation among subsets of cancer cells. In this proposal, we will thus focus on EGFRvIII-MV merge with the plasma membranes of the cancer cells lacking EGFRvIII, and whether this event leads to the transfer of the oncogenic activity, including activation of PI3K/Akt/DNA-PK signalling pathway, acceleration of DNA DSB repair and promotion of GBM radioresistance or not. Findings are expected to advance our understanding of the molecular mechanisms that radiation-induced microvesicles modulate radiosensitivity in glioblastoma and provide a promising strategy for radiosensitization of glioblastoma.
多形性胶质母细胞瘤(GBM) 是一类由不同表型和生物学行为的细胞亚群构成的、高度异质性的中枢神经系统病变,微环境和肿瘤细胞之间是密不可分的功能整体。然而,既往研究多以单一细胞为研究对象,忽视了微环境下异质性细胞间的通讯和对话,难以实现临床转化。本项目首次以微泡这一新型胞间通讯载体为对象,以“EGFRvIII阳性微泡促进受体细胞DNA DSB修复,下调其放射敏感性”这一现象为切入点,通过为期4年的实验研究,创新性发现:1)EGFRvIII-MV通过膜融合途径使受体细胞获得EGFRvIII表型,选择性激活PI3K/Akt信号途径,并通过“Akt-DNA-PKcs正反馈环”活化DNA-PK,促进DSB修复,进而下调GBM细胞的放射敏感性;2)靶向干预EGFRvIII-MV的释放和膜融合过程能有效提高GBM放射敏感性;3)GBM患者外周血中EGFRvIII-MV浓度与GBM患者放疗疗效和预后呈负相关。本项目证实了“异质性肿瘤细胞通过微泡横向传递EGFRvIII协同抵抗电离辐射”这一假说,为肿瘤放射增敏提供新视角和新靶点,同时也为临床上放疗增敏药物的开发、遴选提供新途径。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Bio-inspired synthesis of PEGylated Polypyrrole@Polydopamine Nanocomposite as Theranostic agent for T1-Weighted MR imaging guided Photothermal Therapy
仿生合成聚乙二醇化聚吡咯@聚多巴胺纳米复合材料作为T-1加权磁共振成像引导光热治疗的治疗诊断剂
DOI:10.1039/c6tb02740g
发表时间:2017
期刊:JOURNAL OF MATERIALS CHEMISTRY B
影响因子:7
作者:Zhe Yang;Jinghua Ren;Zhilan Ye;Wei Zhu;Liji Xiao;Li Zhang;Qianyuan He;Zushun Xu;Haibo Xu
通讯作者:Haibo Xu
Association between CHRNA3 rs1051730 Genotype and Lung Cancer Risk in Chinese Han Population: A Case-Control Study
CHRNA3 rs1051730 基因型与中国汉族人群肺癌风险的关联:病例对照研究
DOI:10.1007/s11596-013-1218-4
发表时间:2013-12-01
期刊:JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES
影响因子:--
作者:Ren, Jing-hua;Jin, Min;Zhang, Tao
通讯作者:Zhang, Tao
Blockage of Autophagy in C6 Glioma Cells Enhanced Radiosensitivity Possibly by Attenuating DNA-PK-Dependent DSB Due to Limited Ku Nuclear Translocation and DNA Binding
由于 Ku 核易位和 DNA 结合有限,C6 胶质瘤细胞中自噬的阻断可能通过减弱 DNA-PK 依赖性 DSB 来增强放射敏感性
DOI:10.2174/1566524015666150831141112
发表时间:2015-01-01
期刊:CURRENT MOLECULAR MEDICINE
影响因子:2.5
作者:Liu, C.;He, W.;Ren, J.
通讯作者:Ren, J.
DOI:10.1039/C7TB02818K.
发表时间:2018
期刊:Albumin/sulfonamides stabilized iron porphyrin metal organic frameworks nanocomposites: targeting tu
影响因子:--
作者:Zhu W;Liu Y;Yang Z;Zhang L;Xiao L;Liu P;Wang J;Yi C;Xu Z;Ren J
通讯作者:Ren J
Polydopamine-Enabled Approach toward Tailored Plasmonic Nanogapped Nanoparticles: From Nanogap Engineering to Multifunctionality.
聚多巴胺实现定制等离子体纳米间隙纳米粒子的方法:从纳米间隙工程到多功能性
DOI:10.1021/acsnano.6b05951
发表时间:2016-12-27
期刊:ACS nano
影响因子:17.1
作者:Zhou J;Xiong Q;Ma J;Ren J;Messersmith PB;Chen P;Duan H
通讯作者:Duan H
NET-DNA通过降解活化性受体NKp46引起NK失能:肿瘤术后复发转移的新机制
- 批准号:--
- 项目类别:面上项目
- 资助金额:51万元
- 批准年份:2022
- 负责人:任精华
- 依托单位:
Fn14-AuNNP联合光热治疗克服放疗抵抗防治脑胶质瘤复发的功能及机制研究
- 批准号:--
- 项目类别:面上项目
- 资助金额:55万元
- 批准年份:2020
- 负责人:任精华
- 依托单位:
YB-1选择性清除miR-125b/外泌体促进肿瘤干细胞异质性演化:脑胶质瘤放疗抵抗的新伎俩?
- 批准号:81874084
- 项目类别:面上项目
- 资助金额:58.0万元
- 批准年份:2018
- 负责人:任精华
- 依托单位:
hvps34/beclin-1自噬信号上调DNA-PK促进DNA DSB修复:多形性胶质母细胞瘤放射抵抗的新机制?
- 批准号:30900383
- 项目类别:青年科学基金项目
- 资助金额:19.0万元
- 批准年份:2009
- 负责人:任精华
- 依托单位:
国内基金
海外基金
